Valiant Organics Limited — Others, 13-08-2025: Appointment

Valiant Organics has announced a board meeting where it approved the financial results for the quarter ended June 30, 2025. Consolidated revenue from operations reached 204.41 Cr, with a net profit of 8.20 Cr, marking a significant turnaround from a loss in the prior year. Basic EPS improved to Rs. 2.93. The board also appointed M/s. Mehta & Mehta as Secretarial Auditor for five years, pending shareholder approval. Additionally, the company commenced a manufacturing agreement with Aarti Pharmalabs, which is positive for operational scale.